How have SHTDY shares performed in 2024?

Sinopharm Group's stock was trading at $13.05 at the start of the year. Since then, SHTDY stock has decreased by 2.9% and is now trading at $12.67. View the best growth stocks for 2024 here .

Are investors shorting Sinopharm Group?

Sinopharm Group saw a increase in short interest in March. As of March 31st, there was short interest totaling 29,900 shares, an increase of 33.5% from the March 15th total of 22,400 shares. Based on an average trading volume of 17,500 shares, the days-to-cover ratio is presently 1.7 days. View Sinopharm Group's Short Interest .

How often does Sinopharm Group pay dividends? What is the dividend yield for Sinopharm Group?

Sinopharm Group declared a dividend on Thursday, June 15th. Stockholders of record on Friday, June 16th will be given a dividend of $0.4862 per share on Tuesday, August 29th. This represents a dividend yield of 2.85%. The ex-dividend date of this dividend is Thursday, June 15th. Read our dividend analysis for SHTDY .

How do I buy shares of Sinopharm Group?

Shares of SHTDY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:SHTDY

Sinopharm Group (SHTDY) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free SHTDY Stock Alerts

$12.67

+0.14 (+1.12%)

(As of 04/19/2024 ET)

Compare

Today's Range: $12.67
▼
$12.72
50-Day Range: $12.21
▼
$14.44
52-Week Range: $11.36
▼
$18.01

Volume: 12,108 shs
Average Volume: 13,490 shs
Market Capitalization: N/A

P/E Ratio: 2.54
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Dividend Financials Headlines Short Interest

Get Sinopharm Group alerts:

Ad Crypto 101 Media

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

About Sinopharm Group Stock (OTCMKTS:SHTDY)

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd.

SHTDY Stock Price History

30 days | 90 days | 365 days | Advanced Chart

SHTDY Stock News Headlines

April 15, 2024 | americanbankingnews.com

Short Interest in Sinopharm Group Co. Ltd. (OTCMKTS:SHTDY) Expands By 33.5%

April 13, 2024 | morningstar.com

Sinopharm Group Co Ltd

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

April 8, 2024 | msn.com

Study: Pfizer vaccine showed strongest immune response in Morocco

March 27, 2024 | markets.businessinsider.com

Buy Rating for Sinopharm Group Co. Amidst Market Consolidation and Efficiency Gains

March 15, 2024 | tmcnet.com

Xinhua Silk Road: Electric tricycles made in E. China's Rizhao popular abroad

February 25, 2024 | msn.com

Sinopharm Group Co. - Depositary Receipt () (SHTDY) Price Target Increased by 11.16% to 15.28

February 22, 2024 | msn.com

Hong Kong Stocks: Sinopharm to Buyout China-TCM for HK$23.2B

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

February 21, 2024 | uk.finance.yahoo.com

Pharma Wholesale and Distribution market is projected to grow at a CAGR of 8.7% by 2034: Visiongain

February 19, 2024 | thestreet.com

Sinopharm Group Co Ltd ADR

November 7, 2023 | morningstar.com

Sinopharm Group Co Ltd ADR SHTDY

September 5, 2023 | finance.yahoo.com

Hong Kong stocks slide amid China property default risk while Sinopharm slides on index debut, L'Occitane crashes

May 18, 2023 | msn.com

WHO recommends updating COVID shots to add XBB.1 variants

March 30, 2023 | marketwatch.com

Chlorpheniramine Maleate Market Outlook and Forecast till 2031

March 29, 2023 | morningstar.com

Sinopharm’s Earnings Slightly Better Than Expected

March 29, 2023 | marketwatch.com

2023-2029 Gold(III) Bromide (AuBr3) Market Size and Industrial Overview with Region Footprint | Latest Report by Absolute Reports

March 28, 2023 | marketwatch.com

7-Aminocephalosporanic Acid (7-ACA) Market Outlook By 2031

March 27, 2023 | marketwatch.com

Specialty Pharmacy Services Market Outlook By 2031

March 24, 2023 | marketwatch.com

Gosling Plague Vaccine Market Top Players By 2031

March 23, 2023 | marketwatch.com

New Report Predicts Significant Growth in Polysorbate 40 Market from 2023 to 2030

March 21, 2023 | marketwatch.com

Global Cobamamide Drugs Market: Future Extrapolations and Emerging Updates for 2023-2027

March 21, 2023 | marketwatch.com

Chain Drugstores Market Top Players and Forecast till 2029

March 13, 2023 | marketwatch.com

Ammonium Phosphomolybdate Market Size, Share and Forecast 2028 with Top Countries Data

March 13, 2023 | marketwatch.com

Chain Drugstores Market Size 2023 Will Grow Rapidly Another Level In The Forthcoming Year 2029

March 10, 2023 | marketwatch.com

Tacrolimus Consumption Market Size, Growth Rate, Key Players Share, Trends Analysis with Forecast 2023-2029

March 8, 2023 | marketwatch.com

Polysorbate 40 Market Size 2023 Will Grow Rapidly Another Level In The Forthcoming Year 2030

See More Headlines

Receive SHTDY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sinopharm Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Medical Distribution
Sub-Industry: N/A
Current Symbol: OTCMKTS:SHTDY
CUSIP: N/A
CIK: 1556605
Web: www.sinopharmgroup.com.cn
Phone: 86-21-2305-2666
Fax: N/A
Employees: 115,959
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 2.51
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Mr. Qingming Yu (Age 60)
Executive Chairman of the Board
Comp: $896.92k
Mr. Yong Liu (Age 55)
President & Executive Director
Comp: $867.34k
Ms. Xiaojuan Li (Age 48)
Chief Financial Officer
Mr. Yijian Wu (Age 54)
Secretary to the Board, Company Secretary & Authorised Representative

Key Competitors

View All Competitors

SHTDY Stock Analysis - Frequently Asked Questions

How have SHTDY shares performed in 2024?: Sinopharm Group's stock was trading at $13.05 at the start of the year. Since then, SHTDY stock has decreased by 2.9% and is now trading at $12.67.
View the best growth stocks for 2024 here.
Are investors shorting Sinopharm Group?: Sinopharm Group saw a increase in short interest in March. As of March 31st, there was short interest totaling 29,900 shares, an increase of 33.5% from the March 15th total of 22,400 shares. Based on an average trading volume of 17,500 shares, the days-to-cover ratio is presently 1.7 days.
View Sinopharm Group's Short Interest.
How often does Sinopharm Group pay dividends? What is the dividend yield for Sinopharm Group?: Sinopharm Group declared a dividend on Thursday, June 15th. Stockholders of record on Friday, June 16th will be given a dividend of $0.4862 per share on Tuesday, August 29th. This represents a dividend yield of 2.85%. The ex-dividend date of this dividend is Thursday, June 15th.
Read our dividend analysis for SHTDY.
How do I buy shares of Sinopharm Group?: Shares of SHTDY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:SHTDY) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Sinopharm Group (SHTDY) Stock Price, News & Analysis

About Sinopharm Group Stock (OTCMKTS:SHTDY)

SHTDY Stock Price History

SHTDY Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

SHTDY Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info